Asymmetry Ventures Investor
Early stage venture firm investing in defensible businesses
.png)
Technology:
Cell_Therapies, SpaceTech
Industry:
AI
Headquarters:
San Francisco, California, United States
Employees Number:
1-10
Investor Type:
Venture Capital
Investment Stage:
Early Stage Venture, Seed, Venture
Number Of Exits:
5
Investors Number:
191
Estimated Revenue:
$50M to $100M
Register and Claim Ownership